These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37192596)

  • 1. Therapeutic drug monitoring and the therapeutic reference range of levetiracetam for Chinese patients: Problems and issues.
    Shi M; Liu C; He L; Wu H; Wu Y
    Seizure; 2023 Jul; 109():26-33. PubMed ID: 37192596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of levetiracetam concentration in peripheral blood mononuclear cells with clinical efficacy: A sensitive monitoring biomarker in patients with epilepsy.
    Harby SA; Nassra RA; Mekky JF; Ali SM; Ismail CA
    Seizure; 2020 May; 78():71-77. PubMed ID: 32213443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of levetiracetam concentrations in plasma and saliva samples by ultra-performance liquid chromatography-tandem mass spectrometry: Application to therapeutic drug monitoring for pregnant women with epilepsy.
    Zhang M; Jin Y; Li W; He C; Di X; Duan Y; Chen L; Wang Z
    Biomed Chromatogr; 2024 Feb; 38(2):e5777. PubMed ID: 37990827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review on the relevance of therapeutic drug monitoring of levetiracetam.
    Sourbron J; Chan H; Wammes-van der Heijden EA; Klarenbeek P; Wijnen BFM; de Haan GJ; van der Kuy H; Evers S; Majoie M
    Seizure; 2018 Nov; 62():131-135. PubMed ID: 30237016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Drug Monitoring of Levetiracetam in Select Populations.
    Jarvie D; Mahmoud SH
    J Pharm Pharm Sci; 2018; 21(1s):149s-176s. PubMed ID: 30096051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: An observational study in the real world.
    Li R; Zhou Q; Ou S; Wang Y; Li Y; Xia L; Pan S
    Epilepsy Res; 2020 Oct; 166():106408. PubMed ID: 32679487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring in pregnancy: Levetiracetam.
    Fallik N; Trakhtenbroit I; Fahoum F; Goldstein L
    Epilepsia; 2024 May; 65(5):1285-1293. PubMed ID: 38400747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of serum levetiracetam concentrations on therapeutic response and IL1-beta concentration in patients with epilepsy.
    Gulcebi MI; Kendirli T; Turgan ZA; Patsalos PN; Onat Yilmaz F
    Epilepsy Res; 2018 Dec; 148():17-22. PubMed ID: 30326332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures.
    Abdelmesih SK; Elkhateeb N; Zakaria M; Girgis MY
    Seizure; 2021 Oct; 91():263-270. PubMed ID: 34246881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapidity of CNS Effect on Photoparoxysmal Response for Brivaracetam vs. Levetiracetam: A Randomized, Double-blind, Crossover Trial in Photosensitive Epilepsy Patients.
    Reed RC; Rosenfeld WE; Lippmann SM; Eijkemans RMJC; Kasteleijn-Nolst Trenité DGA
    CNS Drugs; 2020 Oct; 34(10):1075-1086. PubMed ID: 32949370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of extended-release levetiracetam in epileptic dogs when administered alone, with phenobarbital or zonisamide.
    Muñana KR; Otamendi AJ; Nettifee JA; Papich MG
    J Vet Intern Med; 2018 Sep; 32(5):1677-1683. PubMed ID: 30238679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of levetiracetam in human plasma by liquid chromatography-tandem mass spectrometry: application to therapeutic drug monitoring.
    Matar KM
    J Pharm Biomed Anal; 2008 Nov; 48(3):822-8. PubMed ID: 18603399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of therapeutic drug monitoring for levetiracetam in pediatric patients with epilepsy.
    Yamamoto Y; Ohta A; Usui N; Imai K; Kagawa Y; Takahashi Y
    Brain Dev; 2023 May; 45(5):285-292. PubMed ID: 36759254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and Pharmacodynamic Evaluation of Intravenous Levetiracetam in Children With Epilepsy.
    Kim MJ; Yum MS; Yeh HR; Ko TS; Lim HS
    J Clin Pharmacol; 2018 Dec; 58(12):1586-1596. PubMed ID: 30052270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of perampanel with concomitant levetiracetam for patients with drug-resistant epilepsy.
    Kanemura H; Sano F; Aihara M
    Eur J Paediatr Neurol; 2019 Jan; 23(1):197-203. PubMed ID: 30424990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Levetiracetam Concentration With Seizure Frequency in Pregnant Women With Epilepsy.
    Schelhaas M; Wegner I; Edens M; Wammes-Van Der Heijden E; Touw D; Ter Horst P
    Neurology; 2023 Jan; 100(2):e172-e181. PubMed ID: 36257713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
    Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
    Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the anticonvulsant activity of levetiracetam dose-dependent?
    Lamouret V; Kurth C; Intravooth T; Steinhoff BJ
    Seizure; 2020 Dec; 83():197-202. PubMed ID: 33197757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study.
    Liguori C; Izzi F; Manfredi N; D'Elia A; Mari L; Mercuri NB; Fabio P
    Epilepsy Behav; 2018 Mar; 80():173-176. PubMed ID: 29414548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
    Abou-Khalil B; Hemdal P; Privitera MD
    Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.